Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilars: FDA, EMA Developing Common Data Package Guidance

Apr 23 2014

• By Derrick Gingery

Related Content

Biosimilars: Does Low BsUFA Fee Revenue Suggest Sponsor Interest Has Stalled?

Apr 08 2013

Biosimilars in 2014: An Interview With FDA New Drugs Head John Jenkins

Mar 04 2014

EMA Prepares For Biosimilar Reference Data From Non-EU Sources; U.S. Input Vital

Oct 10 2012

FDA Biosimilars Guidances Address Immunogenicity Studies, European Bridge Data, Analytics

Feb 13 2012

FDA, EMA Seek Biosimilar Pathway Convergence

Sep 26 2011

Teva’s G-CSF Product Clears FDA, Leaving Appeal Of Biosimilar Pathway Uncertain

Sep 03 2012

Naming Rights: Biosimilar Influence Efforts Continue Before Products Take The Field

Oct 28 2013

Related Companies

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States Europe Drug Approval Standards BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window